GGrantIndex
Sort

16,179 grants matching malaria

Applied Clinical Informatics

$8,286,377
James Mork · National Library Of Medicine · ZIH · FY2023 · LM

DCTD Biopharmaceutical Development

$8,170,255
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

RANDOMIZED TRIAL TO EVALUATE MIRASOL WHOLE BLOOD PATHOGEN REDUCTION TECHNOLOGY SYSTEM TO REDUCE MALARIA AND EMERGINE TRANSFUSION TRASMIT INFECTIONS

$8,151,587
The Johns Hopkins University · · FY2018 · Defense Health Agency

Vaccines to Interrupt Malaria Transmission: Clinical Development

$8,068,044
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

TULANE NATINAL PRIMATE RESEARCH CENTER

$8,038,661
Tulane University Of Louisiana · P51 · FY2004 · RR

Vaccine Immunology Program

$8,027,794
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Applied Clinical Informatics

$8,002,291
James Mork · National Library Of Medicine · ZIH · FY2024 · LM

Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource

$8,000,000
Amber Mallory · Texas Biomedical Research Institute · C06 · FY2023 · OD

REGIONAL PRIMATE RESEARCH CENTER

$7,879,003
Tulane University Of Louisiana · P51 · FY2002 · RR

High-throughput screening for novel adjuvant discovery for vaccines against influenza virus

$7,748,631
Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2014 · AI

Vaccine Immunology Program

$7,744,191
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA

$7,594,868
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Vaccine Immunology Program

$7,577,903
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Biodefense/Emerging Infection Vaccine Studies

$7,568,442
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

DCTD Biopharmaceutical Development

$7,548,939
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Kaiser Washington VTEU supplement 20-0003

$7,505,188
Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2020 · AI

GH21-003, Advancing Public Health Research in Kenya

$7,500,000
M Kariuki Njenga · Washington State University · U01 · FY2023 · GH

GH21-003, Advancing Public Health Research in Kenya

$7,426,960
M Kariuki Njenga · Washington State University · U01 · FY2022 · GH

TULANE NATIONAL PRIMATE RESEARCH CENTER

$7,416,004
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2007 · RR

TULANE NATINAL PRIMATE RESEARCH CENTER

$7,414,175
Alan Marshall Miller · Tulane University Of Louisiana · P51 · FY2006 · RR

Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA

$7,278,594
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Vaccine Immunology Program

$7,267,156
Sarah Andrews · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Vaccine Immunology Program

$7,267,155
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

DCTD Biopharmaceutical Development

$7,145,669
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA

Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory

$7,131,815
Gary Kobinger · University Of Texas Med Br Galveston · G20 · FY2022 · AI